Parathyroid cell growth in patients with advanced secondary hyperparathyroidism

Vitamin D receptor and cyclin-dependent kinase inhibitors, p21 and p27

Masanori Tokumoto, Kazuhiko Tsuruya, Kyoichi Fukuda, Hidetoshi Kanai, Shoji Kuroki, Hideki Hirakata, Mitsuo Iida

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Uraemic patients with advanced secondary hyperparathyroidism (2HPT) have nodular hyperplastic glands with a decreased vitamin D receptor (VDR) density. Previous studies have shown that nodular hyperplasia expressed a significantly lower VDR density as compared with diffuse hyperplasia, and the VDR density negatively correlated with both the glandular weight and the marker of cell proliferation. However, the mechanism by which the decreased VDR density leads to parathyroid cell proliferation remains unclear. In the myelomonocytic cell line, active vitamin D3 is known to activate the transcription of both p21 and p27, cyclin-dependent kinase inhibitors (CDKIs), regulating the transition from the G1 to the S phase of the cell cycle, in a VDR-dependent manner. Moreover, the overexpression of p21 and p27 inhibits cell proliferation. In order to elucidate the mechanism of parathyroid cell proliferation, the expression of CDKIs, p21 and p27, and the VDR was analysed immunohistochemically, and compared among nodular and diffuse hyperplastic parathyroid glands, and histologically normal parathyroid glands. The VDR expression in nodular hyperplasias was significantly decreased compared with either diffuse hyperplasias or normal parathyroid glands. The expression of both p21 and p27 was also significantly lower in nodular hyperplasias than in diffuse hyperplasias or normal parathyroid glands. Sections of parathyroid glands with a high expression of nuclear VDR highly expressed both p21 and p27. In nodular hyperplasias, the expression of both p21 and p27 correlated either positively with the nuclear VDR expression or inversely with the glandular weight. Therefore, the reduced expression of p21 and p27, being VDR dependent, is a major pathogenic factor for nodular parathyroid gland growth in advanced 2HPT.

Original languageEnglish
JournalNephrology Dialysis Transplantation
Volume18
Issue numberSUPPL. 3
Publication statusPublished - Jun 1 2003

Fingerprint

Cyclin-Dependent Kinase Inhibitor p21
Cyclin-Dependent Kinase Inhibitor p27
Calcitriol Receptors
Secondary Hyperparathyroidism
Parathyroid Glands
Hyperplasia
Growth
Cell Proliferation
Weights and Measures
Cholecalciferol
S Phase
Cell Cycle

All Science Journal Classification (ASJC) codes

  • Nephrology
  • Transplantation

Cite this

Parathyroid cell growth in patients with advanced secondary hyperparathyroidism : Vitamin D receptor and cyclin-dependent kinase inhibitors, p21 and p27. / Tokumoto, Masanori; Tsuruya, Kazuhiko; Fukuda, Kyoichi; Kanai, Hidetoshi; Kuroki, Shoji; Hirakata, Hideki; Iida, Mitsuo.

In: Nephrology Dialysis Transplantation, Vol. 18, No. SUPPL. 3, 01.06.2003.

Research output: Contribution to journalArticle

Tokumoto, Masanori ; Tsuruya, Kazuhiko ; Fukuda, Kyoichi ; Kanai, Hidetoshi ; Kuroki, Shoji ; Hirakata, Hideki ; Iida, Mitsuo. / Parathyroid cell growth in patients with advanced secondary hyperparathyroidism : Vitamin D receptor and cyclin-dependent kinase inhibitors, p21 and p27. In: Nephrology Dialysis Transplantation. 2003 ; Vol. 18, No. SUPPL. 3.
@article{bb59c01f359942cc9cd3bb6cd39d29b5,
title = "Parathyroid cell growth in patients with advanced secondary hyperparathyroidism: Vitamin D receptor and cyclin-dependent kinase inhibitors, p21 and p27",
abstract = "Uraemic patients with advanced secondary hyperparathyroidism (2HPT) have nodular hyperplastic glands with a decreased vitamin D receptor (VDR) density. Previous studies have shown that nodular hyperplasia expressed a significantly lower VDR density as compared with diffuse hyperplasia, and the VDR density negatively correlated with both the glandular weight and the marker of cell proliferation. However, the mechanism by which the decreased VDR density leads to parathyroid cell proliferation remains unclear. In the myelomonocytic cell line, active vitamin D3 is known to activate the transcription of both p21 and p27, cyclin-dependent kinase inhibitors (CDKIs), regulating the transition from the G1 to the S phase of the cell cycle, in a VDR-dependent manner. Moreover, the overexpression of p21 and p27 inhibits cell proliferation. In order to elucidate the mechanism of parathyroid cell proliferation, the expression of CDKIs, p21 and p27, and the VDR was analysed immunohistochemically, and compared among nodular and diffuse hyperplastic parathyroid glands, and histologically normal parathyroid glands. The VDR expression in nodular hyperplasias was significantly decreased compared with either diffuse hyperplasias or normal parathyroid glands. The expression of both p21 and p27 was also significantly lower in nodular hyperplasias than in diffuse hyperplasias or normal parathyroid glands. Sections of parathyroid glands with a high expression of nuclear VDR highly expressed both p21 and p27. In nodular hyperplasias, the expression of both p21 and p27 correlated either positively with the nuclear VDR expression or inversely with the glandular weight. Therefore, the reduced expression of p21 and p27, being VDR dependent, is a major pathogenic factor for nodular parathyroid gland growth in advanced 2HPT.",
author = "Masanori Tokumoto and Kazuhiko Tsuruya and Kyoichi Fukuda and Hidetoshi Kanai and Shoji Kuroki and Hideki Hirakata and Mitsuo Iida",
year = "2003",
month = "6",
day = "1",
language = "English",
volume = "18",
journal = "Nephrology Dialysis Transplantation",
issn = "0931-0509",
publisher = "Oxford University Press",
number = "SUPPL. 3",

}

TY - JOUR

T1 - Parathyroid cell growth in patients with advanced secondary hyperparathyroidism

T2 - Vitamin D receptor and cyclin-dependent kinase inhibitors, p21 and p27

AU - Tokumoto, Masanori

AU - Tsuruya, Kazuhiko

AU - Fukuda, Kyoichi

AU - Kanai, Hidetoshi

AU - Kuroki, Shoji

AU - Hirakata, Hideki

AU - Iida, Mitsuo

PY - 2003/6/1

Y1 - 2003/6/1

N2 - Uraemic patients with advanced secondary hyperparathyroidism (2HPT) have nodular hyperplastic glands with a decreased vitamin D receptor (VDR) density. Previous studies have shown that nodular hyperplasia expressed a significantly lower VDR density as compared with diffuse hyperplasia, and the VDR density negatively correlated with both the glandular weight and the marker of cell proliferation. However, the mechanism by which the decreased VDR density leads to parathyroid cell proliferation remains unclear. In the myelomonocytic cell line, active vitamin D3 is known to activate the transcription of both p21 and p27, cyclin-dependent kinase inhibitors (CDKIs), regulating the transition from the G1 to the S phase of the cell cycle, in a VDR-dependent manner. Moreover, the overexpression of p21 and p27 inhibits cell proliferation. In order to elucidate the mechanism of parathyroid cell proliferation, the expression of CDKIs, p21 and p27, and the VDR was analysed immunohistochemically, and compared among nodular and diffuse hyperplastic parathyroid glands, and histologically normal parathyroid glands. The VDR expression in nodular hyperplasias was significantly decreased compared with either diffuse hyperplasias or normal parathyroid glands. The expression of both p21 and p27 was also significantly lower in nodular hyperplasias than in diffuse hyperplasias or normal parathyroid glands. Sections of parathyroid glands with a high expression of nuclear VDR highly expressed both p21 and p27. In nodular hyperplasias, the expression of both p21 and p27 correlated either positively with the nuclear VDR expression or inversely with the glandular weight. Therefore, the reduced expression of p21 and p27, being VDR dependent, is a major pathogenic factor for nodular parathyroid gland growth in advanced 2HPT.

AB - Uraemic patients with advanced secondary hyperparathyroidism (2HPT) have nodular hyperplastic glands with a decreased vitamin D receptor (VDR) density. Previous studies have shown that nodular hyperplasia expressed a significantly lower VDR density as compared with diffuse hyperplasia, and the VDR density negatively correlated with both the glandular weight and the marker of cell proliferation. However, the mechanism by which the decreased VDR density leads to parathyroid cell proliferation remains unclear. In the myelomonocytic cell line, active vitamin D3 is known to activate the transcription of both p21 and p27, cyclin-dependent kinase inhibitors (CDKIs), regulating the transition from the G1 to the S phase of the cell cycle, in a VDR-dependent manner. Moreover, the overexpression of p21 and p27 inhibits cell proliferation. In order to elucidate the mechanism of parathyroid cell proliferation, the expression of CDKIs, p21 and p27, and the VDR was analysed immunohistochemically, and compared among nodular and diffuse hyperplastic parathyroid glands, and histologically normal parathyroid glands. The VDR expression in nodular hyperplasias was significantly decreased compared with either diffuse hyperplasias or normal parathyroid glands. The expression of both p21 and p27 was also significantly lower in nodular hyperplasias than in diffuse hyperplasias or normal parathyroid glands. Sections of parathyroid glands with a high expression of nuclear VDR highly expressed both p21 and p27. In nodular hyperplasias, the expression of both p21 and p27 correlated either positively with the nuclear VDR expression or inversely with the glandular weight. Therefore, the reduced expression of p21 and p27, being VDR dependent, is a major pathogenic factor for nodular parathyroid gland growth in advanced 2HPT.

UR - http://www.scopus.com/inward/record.url?scp=0037677270&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037677270&partnerID=8YFLogxK

M3 - Article

VL - 18

JO - Nephrology Dialysis Transplantation

JF - Nephrology Dialysis Transplantation

SN - 0931-0509

IS - SUPPL. 3

ER -